CytRx Corporation (Nasdaq: CYTR) announced the appointment of Shanta Chawla, M.D. as Vice President, Clinical Development. Dr. Chawla has more ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE